HEPH

HEPH: To Present At Lazard Capital Healthcare Conference @ 13:40 ET [delayed] - 11/18 - 12:23 PM ET

Richard Hollis, Chairman, President and CEO of Hollis-Eden Pharmaceuticals Talks to The Wall Street Transcript - 11/17 - 09:28 AM ET

HEPH: To Present At Rodman & Renshaw Investment Conference @ 10:20 ET [delayed] - 11/10 - 08:54 AM ET

HEPH: To Present At Rodman & Renshaw Investment Conference @ 09:55 ET [delayed] - 11/10 - 08:23 AM ET

Hollis-Eden Pharmaceuticals Updates Upcoming Investor Conference Presentations and Webcasts - 11/07 - 07:00 AM ET

HEPH: Q3 Earnings Call @ 14:00 ET Today [delayed] - 11/06 - 11:20 AM ET

BRIEF-Hollis-Eden Q3 results - 11/06 - 07:16 AM ET

HEPH: To Present At BIO Investor Conference @ 14:30 ET [delayed] - 10/30 - 12:53 PM ET

HEPH: To Present At BIOCOM Investor Conference @ 19:30 ET [delayed] - 10/27 - 05:53 PM ET

Hollis-Eden Pharmaceuticals to Webcast Investor Conference Presentations and Third Quarter 2008 Conference Call - 10/15 - 07:00 AM ET

Hollis-Eden Pharmaceuticals Picks Up Volume, Challenges Resistance - 10/14 - 12:42 PM ET

Hollis-Eden reports additional findings from Phase I/II prostate cancer study - 09/29 - 11:25 AM ET

HEPH: Reports New Positive Preclinical Data re APOPTONE(TM) in Prostate Cancer - 09/29 - 08:05 AM ET

Hollis-Eden Pharmaceuticals Presents Additional Positive Findings for APOPTONE(TM) (HE3235) in Preclinical Models of Castration-Resistant Prostate Cancer - 09/29 - 07:00 AM ET

Hollis-Eden reports positive interim data from Phase I/II diabetes trial - 09/26 - 11:11 AM ET

HEPH: To Present At Merriman Curhan Ford Investor Conference @ 18:00 ET [delayed] - 09/15 - 04:23 PM ET

Hollis-Eden Pharmaceuticals Reports Update on Autoimmunity Program with TRIOLEX(TM) (HE3286) at International Autoimmunity Meeting - 09/12 - 07:00 AM ET

Hollis-Eden Pharmaceuticals to Present at the Merriman Curhan Ford 5th Annual Investor Summit - 09/11 - 07:00 AM ET

HEPH: Q2 Earnings Call @ 14:00 ET Today [delayed] - 08/07 - 11:22 AM ET

Hollis-Eden Pharmaceuticals Reports on Progress in Drug Development Programs; Announces Second Quarter 2008 Financial Results - 08/07 - 07:00 AM ET

Page 1 of 4     1  2   3   4      Previous  |  Next

<< Back to Stock Index